258 related articles for article (PubMed ID: 1519576)
21. Famotidine in the management of duodenal ulcer: an analysis of multicenter findings worldwide.
Reynolds JC
Clin Ther; 1988; 10(4):436-49. PubMed ID: 3079011
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for delayed healing of duodenal ulcers treated with famotidine and ranitidine.
Reynolds JC; Schoen RE; Maislin G; Zangari GG
Am J Gastroenterol; 1994 Apr; 89(4):571-80. PubMed ID: 8147361
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of duodenal ulcer with famotidine].
Schütze K; Hentschel E; Reichel W; Kerstan E
Wien Med Wochenschr; 1987 Sep; 137(17):409-11. PubMed ID: 2891224
[TBL] [Abstract][Full Text] [Related]
24. The histological maturity of regenerating mucosa of healed duodenal ulcer and ulcer recurrence after treatment with H2-antagonist.
Pan S; Liao CH
Am J Gastroenterol; 1990 Aug; 85(8):949-52. PubMed ID: 1973870
[TBL] [Abstract][Full Text] [Related]
25. [Is famotidine--the 3d generation H2 receptor antagonist--a step in progress in the treatment of duodenal ulcer?].
Stasiewicz J; Romatowski J; Kluz A; Szałaj W; Namiot Z
Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1684-6. PubMed ID: 3077455
[No Abstract] [Full Text] [Related]
26. A multicenter, double-blind, randomized controlled study of omeprazole versus ranitidine in the treatment of duodenal ulcer in Israel.
Arber N; Avni Y; Eliakim R; Swissa A; Melzer E; Rachmilewitz D; Konikoff F
Isr J Med Sci; 1994 Oct; 30(10):757-61. PubMed ID: 7960688
[TBL] [Abstract][Full Text] [Related]
27. [Therapy of duodenal ulcer with H2-blockers. 2 x 150 mg ranitidine versus 2 x 400 mg cimetidine].
Hüttemann W
Fortschr Med; 1983 Jan; 101(4):139-41. PubMed ID: 6131857
[TBL] [Abstract][Full Text] [Related]
28. Comparison of nizatidine and cimetidine as once-nightly treatment of acute duodenal ulcer. Nizatidine Multicenter Duodenal Ulcer Study Group.
Cherner JA; Cloud ML; Offen WW; Latz JE
Am J Gastroenterol; 1989 Jul; 84(7):769-74. PubMed ID: 2568086
[TBL] [Abstract][Full Text] [Related]
29. The treatment of duodenal and gastric ulcer with ranitidine--a controlled, multicentre clinical trial.
Gibinski K; Nowak A; Gabryelewicz A; Szalaj W; Hasik J; Klincewicz H; Pokora J; Radwan P; Kosecki P; Pachlewski J
Dtsch Z Verdau Stoffwechselkr; 1982; 42(2-3):64-9. PubMed ID: 6286274
[TBL] [Abstract][Full Text] [Related]
30. Early evening ranitidine administration promotes faster duodenal ulcer healing.
Merki H; Witzel L; Hüttemann W; Ansari A; Panijel M; Harre K; Heim J; Wolbergs E; Neumann HJ; Röhmel J
Am J Gastroenterol; 1988 Apr; 83(4):362-4. PubMed ID: 3279756
[TBL] [Abstract][Full Text] [Related]
31. Famotidine vs ranitidine h.s. in acute duodenal ulcer. A multicentre endoscopic trial.
Bianchi Porro G; Lazzaroni M; Barbara L; Corinaldesi R; Blasi A; Mangiameli A; Capurso L; Koch M; Cheli R; Bovero E
Ital J Gastroenterol; 1991 Feb; 23(2):65-9. PubMed ID: 1747505
[TBL] [Abstract][Full Text] [Related]
32. [Early evening administration of ranitidine in therapy of duodenal ulcer].
Schmidtke-Schrezenmeier G; Klingmann J; Pabst G; Geerke H; Koch EM
Z Gastroenterol; 1990 Dec; 28(12):656-9. PubMed ID: 2087820
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of peptic ulcer with ranitidine and cimetidine in a single nocturnal dose].
Klinger J; Maggiolo P; Arteaga H; Goić A
Rev Med Chil; 1987 Jul; 115(7):645-7. PubMed ID: 3331025
[No Abstract] [Full Text] [Related]
34. Role of histamine-2 receptor antagonists after simple closure of perforated duodenal ulcer--a double blind randomised, controlled study.
Sevvel S; Ananthakrishnan N; Kate V
Trop Gastroenterol; 1996; 17(4):227-9. PubMed ID: 9094865
[TBL] [Abstract][Full Text] [Related]
35. Influence of cigarette smoking on healing and relapse in duodenal ulcer disease.
Korman MG; Hansky J; Eaves ER; Schmidt GT
Gastroenterology; 1983 Oct; 85(4):871-4. PubMed ID: 6136450
[TBL] [Abstract][Full Text] [Related]
36. Different dosage regimens of ranitidine in the short-term therapy of duodenal ulcer: a multicentre trial.
Castelli G; Squassante L; Uleri S; Zanferrari G
Int J Clin Pharmacol Res; 1991; 11(1):41-9. PubMed ID: 1874580
[TBL] [Abstract][Full Text] [Related]
37. Failure of single night-time dose of H2-receptor antagonists in the treatment of duodenal ulcer patients with bulbar stenosis.
Materia A; Genco A; Silecchia G; Basso N
Am J Gastroenterol; 1989 Nov; 84(11):1462-3. PubMed ID: 2816881
[No Abstract] [Full Text] [Related]
38. [Acute therapy of duodenal ulcer. Comparison of famotidine and ranitidine in a single evening dose].
Kimmig JM
Fortschr Med; 1987 Feb; 105(5):72-6. PubMed ID: 3549493
[No Abstract] [Full Text] [Related]
39. [Ranitidine therapy of duodenal ulcer: comparison of once-a-day and twice-a-day administration. A Swiss multicenter double-blind study].
Aenishänslin W; Bergoz R; Capitaine Y; Egger G; Etienne A; Fumagalli I; Güller R; Hammer B; Kobler E; Leuthold E
Schweiz Med Wochenschr; 1986 May; 116(19):637-41. PubMed ID: 3715441
[TBL] [Abstract][Full Text] [Related]
40. Prolonged bedtime treatment with H2-receptor antagonists (ranitidine and famotidine) does not affect blood alcohol levels after ethanol ingestion in male patients with duodenal ulcer.
Casini A; Pizzigallo AM; Mari F; Bertol E; Surrenti C
Am J Gastroenterol; 1994 May; 89(5):745-9. PubMed ID: 8172150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
